Prosiectau (583)
Cardiff University Schools involved in this Project
Pulmonary and cardiovascular toxicology of aerosol pollutants (03.01.2018 - 02.01.2020)
- Ford, William
Pulmonary pharmacokientics of antimicrobial peptides (12.01.2009 - 12.01.2010)
- Gumbleton, Mark
Radiosynthesis of 18F-labelled pro-nucleotides (ProTides) for positron emission tomography (PET) imaging (01.10.2014 - 30.09.2017)
- Westwell, Andrew
Rapid diagnosis of clostridium difficile infection using magneto-optical sensing (01.04.2016 - 31.03.2017)
- Baillie, Les
RAPPIDS: Rapid assay of pathogens with a portable immunosensor for diagnosing sepsis (16.07.2012 - 28.02.2015)
- Allender, Christopher
Rational design of antibody drug conjugate targets - unlocking a goldmine and war chest (01.01.2015 - 31.12.2015)
- Mcguigan, Christopher
Rational design of novel antibody-decorated nanoparticles targeting HER2 positive breast cancer (01.07.2018 - 28.06.2022)
- Jones, Arwyn
RCUK funding workshop (01.02.2017 - 31.07.2017)
- Birchall, James
Refining the drug discovery paradigm for schistosomiasis (01.10.2021 - 30.09.2024)
- Westwell, Andrew
Regulation of neutrophil extracellular traps (NETs) by novel eicosanoids (01.03.2014 - 29.02.2016)
- Clark, Stephen
Relative anti-oxidant and anti-inflammatory capacity in topically delivered extracts (01.06.2012 - 27.07.2012)
- Heard, Charles
Removal of dry surface biofilms of pathogens causing food safety concern by cleaning substrates (19.03.2024 - 19.09.2024)
- Maillard, Jean-Yves
Replication and refinement of proteomic plasma biomarker signature of transition from UHR to psychotic disorder (01.01.2021 - 31.07.2023)
- Heurich-Sevcenco, Meike
Repositioning histone methyltransferase inhibitors as next generation anthelmintics (01.10.2015 - 30.09.2018)
- Mcguigan, Christopher
Research into aspects of cancer (01.01.2005 - 31.03.2012)
- Mcguigan, Christopher
Resistance mechanisms during prolonged antihormone exposure (01.10.2010 - 31.03.2016)
- Gee, Julia
Rethinking repurposing: Developing cryogel technology to address glioblastoma recurrence through year-long local delivery of repurposed therapeutics (01.11.2023 - 30.04.2026)
- Newland, Benjamin
Review formulation information on a novel phage therapeutic medicine for licensing purposes (01.05.2012 - 31.05.2012)
Revision of the methodology used for systematic mapping of the HTA systems in Europe (01.10.2011 - 30.09.2014)
Rivastigmine and quality of life in patients with Parkinson's disease dementia (01.09.2014 - 30.04.2015)
- Lane, Emma
Roboworm 2: An automated high context imaging platform for repositioning old drugs (and discovering new ones) as next generation anthelmintics (19.05.2016 - 30.06.2017)
- Mcguigan, Christopher
Roboworm: An automated high content imaging platform for repositioning old drugs (and discovering new ones) as next generation anthelmintics (18.05.2015 - 30.04.2016)
- Mcguigan, Christopher
Roboworm IV: Development of a motility image analysis model for newly excysted juvenile fasciola hepatica (30.06.2018 - 21.02.2019)
- Brancale, Andrea
Role of DNA repair in resisting treament with gemcitabine and other nucleoside analogues (01.01.2014 - 31.12.2016)
- Mcguigan, Christopher
Role of HER2/HER3, other signalling pathways and the ability of AZD8931 to inhibit the growth of EGFR responsive anti-hormone-resistant breast cancer lines (01.09.2009 - 31.03.2012)
Role of Rho-dependent kinase in mediating reperfusion injury (07.01.2008 - 17.06.2010)
- Baxter, Gary
Roles of trace amine associated receptors in cardiovascular responses to dietary trace amines (01.08.2009 - 30.04.2013)
- Ford, William
Scholarship (01.10.2015 - 05.10.2019)
- Heard, Charles
Scholarship (01.10.2016 - 30.09.2019)
- Prokopovich, Polina
Serology assays of serum samples (01.04.2011 - 31.05.2012)
- Baillie, Les
Serotonin associated injury and survival signalling in myocardium: Receptor dependant and non receptor targets for cytoprotection (01.09.2008 - 18.11.2012)
- Baxter, Gary
Short term effects of an AKT inhibitor (AZD5363) on biomarkers of the pathway and anti-tumour activity in breast cancer paired biopsy study (01.08.2013 - 31.10.2017)
- Gee, Julia
Single molecule imaging of protein transport through the anthrax toxin pore (27.07.2017 - 30.09.2018)
- Castell, Oliver
Single molecule ion channel imaging with nitrogen vacancy diamond in droplet interface bilayers (01.08.2016 - 31.01.2017)
- Castell, Oliver
Skin permeation of gold nanoparticles (01.01.2016 - 31.03.2016)
- Birchall, James
Small-molecule immune checkpoint inhibitors: An innovative approach to treat cancer (10.06.2018 - 30.06.2021)
- Brancale, Andrea
Small molecule inhibitors of Brachyury: Addressing unmet clinical needs by targeting a sub-type of colorectoral cancer with particulary poor patient prognosis (01.09.2017 - 21.02.2019)
- Brancale, Andrea
Small molecule inhibitors of CYP24A1 - Prostate cancer therapeutics (01.10.2009 - 30.09.2013)
- Simons, Claire
Small molecules inhibitors of Ctk to sensitise cancer cells to therapy (01.06.2017 - 31.12.2018)
- Brancale, Andrea
Smart multifunctional nano-carriers with biodegradable and dual responsive properties from hyperbalanced polymers for targeted cancer drug delivery (01.10.2016 - 30.09.2018)
- Brancale, Andrea
SNN microneedle project (01.01.2022 - 30.06.2023)
- Birchall, James
S PHRMY ESF BAILL KESS (01.07.2011 - 31.07.2015)
- Baillie, Les
S PHRMY ESF WHITE KESS (01.07.2011 - 31.07.2015)
- White, Alex
Sporicidal activity of formulations (20.03.2017 - 19.06.2017)
- Maillard, Jean-Yves
Sporicides: effect of protocols on efficacy (05.01.2015 - 04.07.2015)
- Maillard, Jean-Yves
Stem-like features and experimental therapeutics of glioma (01.10.2015 - 30.09.2019)
- Gumbleton, Mark
Studentship (01.01.2018 - 12.12.2022)
- Heard, Charles
Studentship (01.01.2018 - 31.12.2020)
- Simons, Claire
Studentship (01.03.2019 - 29.02.2020)
- Simons, Claire
Studentship (01.04.2015 - 31.03.2018)
- Baillie, Les
Studentship (01.04.2018 - 22.03.2022)
- Prokopovich, Polina
Studentship (01.04.2018 - 31.03.2019)
- Prokopovich, Polina
Studentship (01.04.2018 - 31.03.2022)
- Prokopovich, Polina
Studentship (01.04.2019 - 31.03.2023)
- Baillie, Les
Studentship (01.07.2019 - 25.06.2023)
- Baillie, Les
Studentship (01.07.2019 - 30.09.2022)
- Taylor, Kathryn
Studentship (01.10.2017 - 01.03.2021)
- Ford, William
Studentship (01.10.2017 - 11.09.2021)
- Newland, Benjamin
Studentship (01.10.2017 - 15.01.2022)
- Deslandes, Rhian
Studentship (01.10.2018 - 30.09.2022)
- Gumbleton, Mark
Studentship (01.10.2019 - 01.10.2023)
- Simons, Claire
Studentship (01.10.2019 - 17.09.2023)
- Newland, Benjamin
Studentship (01.10.2020 - 26.10.2024)
- Kidd, Emma
Studentship (01.10.2022 - 30.09.2024)
- Simons, Claire
Studentship (02.01.2019 - 02.01.2023)
- Heard, Charles
Studentship (02.01.2019 - 31.12.2021)
- Prokopovich, Polina
Studentship (04.01.2021 - 03.01.2023)
- Mehellou, Youcef
Studentship (07.07.2021 - 30.06.2024)
- Simons, Claire
Studentship - Development of multimodal drug delivery systems for local therapy in glioblastoma (01.10.2023 - 30.09.2026)
- Newland, Benjamin
Studentship - Hossam Abdelaziz (11.01.2023 - 12.01.2025)
- Simons, Claire
Studentship - Jabril Mohammed M Abdali (04.01.2022 - 04.01.2025)
- Simons, Claire
Studies on the exacerbation of pulmonary inflammation by viral infection (01.09.2008 - 31.01.2012)
- Ford, William
Sublingual delivery (30.01.2012 - 31.03.2012)
- Heard, Charles
Sublingual delivery of vitamin B12 (01.10.2012 - 31.10.2012)
- Heard, Charles
Substrate disinfectant active binding study (01.12.2016 - 30.09.2017)
- Maillard, Jean-Yves
Sugar phosphates for osteoarthritis (01.11.2005 - 16.11.2009)
- Mcguigan, Christopher
Suldecki - ASM Micro 2019 Conference (01.06.2019 - 02.06.2019)
- Maillard, Jean-Yves
Supporting the development of a novel ‘honey tea’ nutraceutical product (01.10.2022 - 31.01.2023)
- Baillie, Les
Surfoxidants for universal decontamination (01.07.2019 - 31.10.2019)
- Maillard, Jean-Yves
Synthesis of novel indole derivatives as apoptosis-inducing antitumour agents (01.01.2007 - 01.01.2010)
- Westwell, Andrew
Synthetic routes of 18F labelled gemicitabine and related 2"-fluoronucleotides (01.10.2011 - 30.09.2014)
- Westwell, Andrew
Synthetic routes to the tumour proliferation biomarker FLT and ProTide analogues for position emission tomography (PET) imaging (01.01.2010 - 01.01.2013)
- Westwell, Andrew
Targeted metabolic inhibition of T-lymphocytes: Directing immunity during human disease (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting CtIP to sensitise cancer cells to DNA-damaging agents (01.11.2016 - 31.03.2018)
- Brancale, Andrea
Targeting natural products to counter the challenge of MRSA (01.10.2014 - 30.09.2017)
- Mcguigan, Christopher
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting zinc signalling to prevent cell division in cancer (01.10.2016 - 30.09.2018)
- Taylor, Kathryn
Targetting zinc signalling to prevent cell division in cancer (01.10.2015 - 30.09.2018)
- Taylor, Kathryn
Technology Transfer Workshop (15.03.2017 - 31.12.2017)
- Gumbleton, Mark
Telehealth enabled medicines for care home residents (01.09.2014 - 31.12.2023)
- James, Delyth
Testing a new skin injection device (15.09.2021 - 28.02.2022)
- Birchall, James
Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs (01.10.2015 - 30.09.2018)
- Mcguigan, Christopher
Testing antimicrobial material acitvity (14.09.2015 - 13.01.2016)
- Maillard, Jean-Yves
Testing for broad spectrum efficacy of photosensitiser-based formulation (01.01.2020 - 31.07.2022)
- Maillard, Jean-Yves
Testing of contamination of Alcoblow(r) (01.04.2013 - 14.04.2013)
- Maillard, Jean-Yves
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (01.09.2012 - 14.09.2012)
- Maillard, Jean-Yves
Testing of the activity of antimicrobial wipe against clostridium difficile and MRSA (28.01.2013 - 27.02.2013)
- Maillard, Jean-Yves
Testing of the efficacy of Byotrol wipes against two bacterial contaminants (14.05.2012 - 31.05.2012)
- Maillard, Jean-Yves
Testing of the new sporicidal activity of 3 new products against clostridium difficile (30.01.2012 - 29.04.2012)
- Maillard, Jean-Yves
Testing of the propensity of Oxy BAC F31 RO (1331) to induce/select/trigger bacterial resistance (01.12.2014 - 09.02.2015)
- Maillard, Jean-Yves